Thyroid News

For pregnant women with well-controlled Graves’ hyperthyroidism, subnormal thyroid-stimulating hormone levels and thyrotropin-receptor antibody positivity at drug withdrawal were linked to a rebound of Graves’ hyperthyroidism.

On a recent workday, I wore this tie to work. It is one of Dr. Daniel Duick's numerous ties.

Most patients with differentiated thyroid cancer on levothyroxine suppression therapy do not have a thyroid-stimulating hormone level within the target range, according to study data published in Clinical Endocrinology.

More than one-third of patients treated for differentiated thyroid cancer reported elevated anxiety and more than 15% reported a high level of depression at an annual follow-up, according to study findings published in Thyroid.

Among patients with type 2 diabetes and normal thyroid function, thyroid hormone levels were linked to nonalcoholic fatty liver disease, suggesting assessment of these hormones might be beneficial for disease prevention and treatment.

ATLANTA — An ultrasound-based artificial intelligence classifier of thyroid nodules identified benign nodules with sensitivity similar to fine-needle aspiration, according to data presented at ENDO 2022.

ATLANTA — COVID-19 vaccination is not associated with changes in thyroid function or an increased risk for adverse outcomes for people with hypothyroidism, according to data presented at ENDO 2022.

Among adults with Graves’ disease, thyroid dysfunction was common and often recurrent during the first 12 months after radioiodine treatment, according to findings from the PRAGMA study.

ATLANTA — In this video exclusive, Terry Smith, MD, discusses results of an analysis of clinical trial data on blood glucose effects associated with teprotumumab therapy for thyroid eye disease.

Both exogenous hyperthyroidism and exogenous hypothyroidism were linked to an elevated risk for cardiovascular mortality, according to results published in JAMA Network Open.